Healthcare

Expenditure On Emergency Rooms

Expenditure On Emergency Rooms

Healthcare

Wandsworth work with number of accountancy practices and were approached to advise our client to analyse the capital expenditure incurred during the construction of 36 emergency rooms in East London. Expenditure totalled £3.1m

Regents Property

Capital Allowances FAQ'S

Read our FAQ's to get the answers you need right now.

What are capital allowances?

Capital allowances are the only means of providing tax relief for capital expenditure incurred by both UK and overseas taxpayers on commercial property. They act as an incentive to invest by saving money for these businesses. They do this by offsetting tax on profits which would otherwise be due by the number of allowances claimed. Capital allowances, therefore, reduce taxable profits for companies, businesses and individuals.

What is the real benefit?

The benefit is simple – we can help reduce your tax liability and therefore you pay a lot less tax. The ‘hidden’ benefit is the peace of mind in knowing that your claim is being prepared by an expert who will produce a detailed report on an open book basis in a technically robust fashion so that you do not have to worry about this part of your tax computation.

How much will it cost me?

Our fees are based on the level of allowances identified and will always be less than the first year tax benefit. If we can’t or won’t save any tax we will not charge you a fee.

Why do they exist?

They act as an incentive for businesses to keep investing in property and other business assets. Capital allowances provide tax relief for capital expenditure on items of plant and machinery. Depreciation of fixed assets is not-allowable and not deducted from taxable profits, so another tax relief is available on this expenditure. Capital allowances were brought in to give relief against tax and help keep the economy healthy.

About Us

Recognised as a market leader in capital allowances and R&D

Get Started With Us Today.

Recognised as a market leader in capital allowances and R&D